Kairos Pharma KAPA
NYSE KAPA
$0.54 -0.06 (-10.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Kairos Pharma (KAPA) Change in Other Operating Assets (2023 - 2025)

Updated

Analysis

Kairos Pharma (KAPA) Change in Other Operating Assets (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Assets Change (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -122.00 Mn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 188.00 Mn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 330.00 Mn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn 13.00 Mn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Kairos Pharma 10.50 Mn -1.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 686,000.00
Mar 31, 2025 -636,000.00
Dec 31, 2024 873,000.00
Sep 30, 2024 1.51 Mn
Jun 30, 2024 -2,000.00
Mar 31, 2024 11,000.00
Dec 31, 2023 -9,000.00
API Access

Kairos Pharma Change in Other Operating Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-assets&ticker=KAPA&period=max&api_key=YOUR_API_KEY